InvestorsHub Logo
icon url

gew59

05/07/13 2:03 PM

#445 RE: bg2002 #444

Well hopefully it will go much higher. According to KAAD, they are in international markets and the FDA will not have the same impact (beverage vs supplement). If it becomes popular in international markets, this will hopefully regain interest in the US.

A popular figure representing the company could be the much needed catalyst. I would hope mgmt is looking into this for when the time is right.

Good action today - all buys.
icon url

Kaad_g

05/07/13 2:51 PM

#446 RE: bg2002 #444

Interesting how the price of a stock is mostly about perception. In 2010 the outstanding shares was 65m, sales at about $3.8m, they lost almost $1m, and people were willing to pay over $1/share for the stock. Today the share count is 70m, sales at about $3m, and it appears they are now able to make a profit, yet nobody wants to pay 3.5 cents for the stock.

They ran into road blocks, with the FDA being the big one I think. That’s probably why they are selling in international markets. I didn’t buy this stock because of the annual that’s due out; I don’t think there will be anything mind blowing in there (I would love to be wrong though). I just think this is the year the company/stock finally breaks out.